Follow the instructions in the “DPI Project Template” for the specified content and required length and formation for each page or section.
Chapter 3 – The main headings in Chapter 3 include:
- Chapter 3: Project Design and Methodology (Introduction)
- Purpose
- Project Planning and Procedures (Subheadings: Interprofessional Collaboration, Project Management Plan, Feasibility)
- Setting and Sample Population (Subheadings: Setting, Population and Sample)
- Data Collection and Procedures (Subheadings: Instruments or Data Source, Variables, Data Integrity and Storage, Data Management)
- Potential Bias and Mitigation
- Ethical Considerations
- Summary
References must be listed – more files can attached if needed for completion –
Expert Solution Preview
Introduction: In this chapter, we will discuss the design and methodology used in the DPI project. We will cover the purpose of the project, project planning and procedures, setting and sample population, data collection and procedures, potential bias and mitigation, ethical considerations, and a summary of the chapter.
Purpose:
The purpose of the DPI project is to evaluate the effectiveness of a new medication in reducing symptoms of a specific medical condition in a targeted patient population. Specifically, the project aims to determine if the medication is safe and well-tolerated, as well as if it improves patient outcomes compared to standard treatments.
Project Planning and Procedures:
Interprofessional collaboration is essential in this project, as it involves medical professionals from multiple disciplines working together to ensure the safe and effective use of the new medication. A project management plan will be developed to ensure that all aspects of the project are organized and managed effectively. The feasibility of the project will also be evaluated to determine if it is practical and achievable within the allotted timeframe and resources.
Setting and Sample Population:
The project will be conducted in a hospital setting, with the selected patient population consisting of adult patients who have been diagnosed with the specific medical condition and who have not responded well to standard treatments. A sample of 100 patients will be recruited for the project, with the inclusion and exclusion criteria clearly defined.
Data Collection and Procedures:
Data will be collected using various instruments, including patient surveys, medical records, and laboratory tests. Variables to be collected include patient demographics, medical history, medication history, symptom severity, and adverse events. Data integrity and storage procedures will be established to ensure the accuracy and security of data, and data management procedures will be implemented to ensure timely data analysis and dissemination.
Potential Bias and Mitigation:
Potential sources of bias in the project include selection bias, measurement bias, and confounding variables. These will be addressed through careful selection of the sample population, using validated instruments for data collection, and controlling for confounders through statistical methods.
Ethical Considerations:
Ethical considerations in the project include obtaining informed consent from all patients, protecting patient confidentiality, and ensuring compliance with all relevant regulations and guidelines. The project will be reviewed and approved by an institutional review board prior to implementation.
Summary:
The DPI project is designed to evaluate the effectiveness of a new medication in reducing symptoms of a specific medical condition in a targeted patient population. It involves interprofessional collaboration, project management planning, and careful consideration of ethical considerations. Data will be collected using various instruments and procedures, and potential sources of bias will be addressed. Overall, the project aims to provide valuable information that can be used to improve patient outcomes and advance medical knowledge.
